Sang Le Overview

  • Primary Position
  • Vice President,...

Sang Le General Information

Biography

Ms. Sang Le served as Vice President, Clinical Operations at New Haven Pharmaceuticals. She has over twenty years of clinical research experience in the pharmaceutical and medical device industries. Before joining our company, Sang held a variety of leadership roles as the Portfolio Lead, Senior Director Clinical Operations, Director Clinical Operations, Director Clinical Project Management, Associate Director Clinical Studies. During her past tenures at InVasc Therapeutics, Shionogi and Co. LTD. (formerly Sciele Pharma, Inc.), Altea Therapeutics, Emory University, as well as at various CROs, Sang demonstrated strong leadership in leading cross-functional global clinical projects in multiple therapeutic areas. Sang earned her Bachelor of Science from Dai Hoc Y Duoc (University of Medicine & Pharmacy) in Vietnam, and received her Master in Business Management from Tulane University. She is also a Certified Project Management Professional (PMP) in the pharmaceutical industry by PMI, and a Certified Clinical Research Coordinator (CCRC) by ACRP.

Contact Information

Primary Position
Vice President, Clinical Operations, New Haven Pharmaceuticals
Education
Tulane University, MBA (Master of Business Administration)
Emory University, Degree
Gender
Female

Sang Le FAQs

  • Who is Sang Le?

    Ms. Sang Le served as Vice President, Clinical Operations at New Haven Pharmaceuticals.

  • How much does Sang Le typically invest?

    Sang Le's median deal size is .

  • What is Sang Le’s main position?

    Sang Le’s primary position is Vice President, Clinical Operations.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »